Despite Horgan’s pre-election endorsement, free PrEP isn’t coming any time soon The BC government is putting the brakes on a pre-election endorsement of free pre-exposure prophylaxis (PrEP) drugs. In a statement to Xtra, the BC Ministry of Health says it will not be rolling out coverage of the HIV-prevention drugs anytime soon, despite a January […]
BC government drags feet on HIV-prevention drug coverage Read More »
A new pilot project modelled after a successful Vancouver-made HIV/AIDS strategy will have teams of medical professionals and other front-line staff regularly check in on thousands of people in the city on opioid-substitution therapy with the goal of making sure they don’t miss a day of treatment. The Best-practice is Oral Opioid agoniSt Therapy Collaborative
B.C. support plan for opioid users modelled after HIV/AIDS strategy Read More »
Whether through testing regularly, using condoms, taking preventative drugs or becoming ‘undetectable’, a new campaign is encouraging Londoners to ‘do it your way’ An innovative new Do It London campaign will run until early 2018 to help reduce HIV transmission in the capital. Funded by London boroughs, and delivered by a specialist team based in
How you can help to prevent HIV Read More »
People who inject drugs have historically represented a population at high risk for hepatitis C virus. However, these patients are often wary of authority figures or entities that might draw attention to or monitor their behavior. This caution may negatively affect their incentive to pursue treatment. The significant side effects of interferon-based therapies – previously
Treating HCV in PWID: New prospects for managing an elusive population Read More »
Entre otros, serÃa útil desde los beneficios fÃsicos para disminuir los efectos secundarios a largo plazo de los medicamentos que mantienen a raya el virus “Las personas con VIH usamos marihuana desde hace 30 años, porque no sólo nos da beneficios desde lo fÃsico sino tambin nos mejora el estado de ánimo”, dijo Estela Carrizo,
VIH: ¿Podría ser la marihuana una terapia complementaria? Read More »
A wild ride: Bob Leahy looks back at what’s happened since PositiveLite.com became the first Canadian organization to sign on to the Undetectable = Untransmittable (U = U) campaign I don’t remember how I first heard about Bruce Richman but it was surely on social media. It was the summer of 2016. Bruce had started
One year ago today, PositiveLite.com endorsed the U=U campaign Read More »
“There is increasing agreement that risk of HIV transmission from a person living with HIV (PLHIV) who is on antiretroviral therapy (ART) and has a continuously undetectable viral load is effectively zero.” This statement has been widely acknowledged by people living with HIV and advocates fighting HIV criminalization laws. However, in many states, the legal
Bob Leahy was in Paris last week covering the big IAS conference on HIV Science. Turns out it was the best he had been to and not just because Undetectable=Untransmittable (U=U) almost stole the show. Here is what else happened. International AIDS Society Conferences come in two sizes. They alternate. Next year will be the
No ordinary affair. IAS 2017 report from Paris, Part One: Conference highlights Read More »
When it comes to LGBT health, Vancouver has been and continues to be at the forefront of medical developments, socially progressive initiatives, and humane responses in the face of discrimination. A prime example is when the HIV/AIDS crisis hit Vancouver in the 1980s. As the epidemic ravaged the city’s queer male community during an era
The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.
BC-CfE researchers will be presenting at this year’s AIDS 2017 conference Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
